Chris currently manages HGF Oppositions and Appeals Team and is the Office Head of our Birmingham Office.
Chris' practice spans the chemical and engineering fields with particular interest in electrochemistry, fuel cells, polymers, ceramics and materials on the chemistry side as well as the health care, FMCG (e-cigarettes), aerospace and construction industries.
Oppositions at the European Patent Office (EPO) provides a majority of Chris' practice where he works on high-value, business-critical patents (defensively and offensively) for a number of large clients.
Chris also has an active due diligence practice, providing advice on IP aspects of commercial M & A deals and has acted as a UK patent expert in foreign litigation.
Chris works with his clients (whether they be multinationals, SMEs or universities) to provide high-quality, focused advice to ensure that maximum returns can be achieved.
"Chris Moore [is a] patent practice leader"
"Chris Moore has his fingers in many technical pies. From chemistry to plastic electronics and fuel cells, his is the number to call for impeccable oppositions and appeals representation."
"Head of oppositions and appeals Chris Moore in Birmingham is a key patent attorney practitioner"
EPO oppositions are the metier of chemist and oppositions and appeals head Chris Moore
Chris is a "patent practice leader"
"[HGF] excels in oppositions and appeals too, and heading up the specialist division for this is chemical and engineering specialist Chris Moore, who appears in proceedings regularly, defending high-value and commercially crucial patents."
November 20th 2020
Chris provides pro bono IP support to a number of business incubators in the West Midlands area, including the Bizz Inn in Birmingham.
Chris regularly talks at various events to provide IP training.
Chris was, until recently, the principal examiner for the UK patent attorney professional examinations (FD4 Infringement and Validity) and is now becoming a mentor for trainees.
The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024. The majority of fees will increase by …Read article
HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …Event details
Porter’s Five Forces model  is just one example of a convenient model for exploring and understanding the forces at play in a competitive marketplace. Michael Porter’s Five Forces model …Read article
In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’ for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …Read article
HGF is pleased to invite you to our upcoming German-language seminar on “Invention and patent searches in public databases” in Salzburg and Dresden. The seminar will showcase how public databases …Event details
“Medical devices and bioinformatics / AI diagnostic feedback – law and practice in Europe and Japan” The EPC does not allow ‘medical use’ claims for medial devices. So how do …Event details
A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted. To many …Read article
Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …Read article
If you would like to discuss how HGF could help you, contact one of our IP specialists.